SYTL2 promotes metastasis of prostate cancer cells by enhancing FSCN1-mediated pseudopodia formation and invasion

BACKGROUND: Metastatic prostate cancer (mPCa) has a poor prognosis with limited treatment options. The high mobility of tumor cells is the key driving characteristic of metastasis. However, the mechanism is complex and far from clarified in PCa. Therefore, it is essential to explore the mechanism of...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zean, Tao, Yiran, Gao, Ze, Peng, Shirong, Lai, Yiming, Li, Kaiwen, Chen, Xu, Huang, Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161564/
https://www.ncbi.nlm.nih.gov/pubmed/37147713
http://dx.doi.org/10.1186/s12967-023-04146-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161564/
https://www.ncbi.nlm.nih.gov/pubmed/37147713
http://dx.doi.org/10.1186/s12967-023-04146-y

Ejemplares similares